Patricia M. Danzon : Citation Profile


Are you Patricia M. Danzon?

University of Pennsylvania

18

H index

26

i10 index

1176

Citations

RESEARCH PRODUCTION:

43

Articles

16

Papers

3

Books

5

Chapters

EDITOR:

1

Books edited

RESEARCH ACTIVITY:

   36 years (1982 - 2018). See details.
   Cites by year: 32
   Journals where Patricia M. Danzon has often published
   Relations with other researchers
   Recent citing documents: 96.    Total self citations: 20 (1.67 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pda291
   Updated: 2023-03-02    RAS profile: 2022-10-31    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon.

Is cited by:

Brekke, Kurt (26)

Pammolli, Fabio (18)

Straume, Odd Rune (18)

Dubois, Pierre (17)

Jelovac, Izabela (16)

Magazzini, Laura (13)

Grembi, Veronica (13)

Jimenez-Martin, Sergi (13)

Pertile, Paolo (12)

Cabrales, Antonio (11)

Suppliet, Moritz (11)

Cites to:

Kyle, Margaret (8)

Cockburn, Iain (8)

Szymanski, Stefan (8)

Valletti, Tommaso (8)

DiMasi, Joseph (7)

Jack, William (6)

Dranove, David (6)

Henderson, Rebecca (5)

Griliches, Zvi (4)

Newhouse, Joseph (4)

Lerner, Josh (4)

Main data


Where Patricia M. Danzon has published?


Journals with more than one article published# docs
Journal of Health Economics5
Health Economics5
Journal of Law and Economics5
Journal of Policy Analysis and Management4
International Journal of the Economics of Business3
Managerial and Decision Economics2
American Economic Review2
The Journal of Business2
The Journal of Legal Studies2

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc10
Monograph / Office of Health Economics3
Working Papers / The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State2

Recent works citing Patricia M. Danzon (2022 and 2021)


YearTitle of citing document
2022Who pays for gifts to physicians? Heterogeneous effects of industry payments on drug costs. (2022). Newham, Melissa ; Valente, Marica. In: Papers. RePEc:arx:papers:2203.01778.

Full description at Econpapers || Download paper

2022The Impact of Acquisitions on Inventors Turnover in the Biotechnology Industry. (2022). Riccaboni, Massimo ; van Lidth, Jeroen ; Parisi, Federica ; Verginer, Luca. In: Papers. RePEc:arx:papers:2203.12968.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2021Acquirers’ Reception of Signals in M&A Markets: Effects of Acquirer Experiences on Target Selection. (2021). Reuer, Jeffrey J ; Wu, Chengwei. In: Journal of Management Studies. RePEc:bla:jomstd:v:58:y:2021:i:5:p:1237-1266.

Full description at Econpapers || Download paper

2022Asymmetric information and insurance cycles. (2022). Garven, James R ; Dicks, David L. In: Journal of Risk & Insurance. RePEc:bla:jrinsu:v:89:y:2022:i:2:p:449-474.

Full description at Econpapers || Download paper

2022The effect of accounting for income tax uncertainty on tax?deductible loss accruals for private insurers. (2022). Lin, Tzuting ; Chow, Travis ; Cheng, Jiang. In: Journal of Risk & Insurance. RePEc:bla:jrinsu:v:89:y:2022:i:2:p:505-544.

Full description at Econpapers || Download paper

2022Medicaid expansion, tort reforms, and medical liability costs. (2022). Grace, Martin ; Chen, Hua ; Luo, Jingshu. In: Journal of Risk & Insurance. RePEc:bla:jrinsu:v:89:y:2022:i:3:p:789-821.

Full description at Econpapers || Download paper

2021How competitive are income annuity providers over time?. (2021). Nikolic, Branislav ; Finke, Michael ; Blanchett, David. In: Risk Management and Insurance Review. RePEc:bla:rmgtin:v:24:y:2021:i:2:p:207-214.

Full description at Econpapers || Download paper

2021A replication study of moral hazard in bodily injury liability auto insurance claims filing decisions. (2021). Kerr, Dana A. In: Risk Management and Insurance Review. RePEc:bla:rmgtin:v:24:y:2021:i:4:p:401-419.

Full description at Econpapers || Download paper

2022ROLE OF ECONOMIC FACTORS IN PROPERTY LIABILITY INSURANCE CONSUMPTION: EMPIRICALLY EXAMINING THE INDIAN MARKET. (2022). Amlan, Ghosh ; Abhijit, Mukherjee. In: Studies in Business and Economics. RePEc:blg:journl:v:17:y:2022:i:1:p:112-129.

Full description at Econpapers || Download paper

2022Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform. (2022). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt R. In: CESifo Working Paper Series. RePEc:ces:ceswps:_9853.

Full description at Econpapers || Download paper

2021The Right to Health and the Health Effects of Denials. (2021). Fernandez Sierra, Manuel ; Bhalotra, Sonia. In: CAGE Online Working Paper Series. RePEc:cge:wacage:586.

Full description at Econpapers || Download paper

2021The right to health and the health effects of denials. (2021). Fernandez Sierra, Manuel ; Bhalotra, Sonia. In: Documentos CEDE. RePEc:col:000089:019555.

Full description at Econpapers || Download paper

2022Which Policies for Vaccine Innovation and Delivery in Europe ?. (2022). Dewatripont, Mathias. In: Working Papers ECARES. RePEc:eca:wpaper:2013/343280.

Full description at Econpapers || Download paper

2021Let us work together: The impact of customer strategic alliances on IPO underpricing and post-IPO performance. (2021). Wang, Xiongyuan ; Chan, Kam C ; Jia, Yibo ; Peng, Xuan. In: Journal of Corporate Finance. RePEc:eee:corfin:v:67:y:2021:i:c:s0929119921000201.

Full description at Econpapers || Download paper

2022Do liquidity constraints affect the investment decisions of California hospitals?. (2022). Lee, Jinhyung ; McCullough, Jeffrey S ; Kim, Jounghyeon. In: Economic Modelling. RePEc:eee:ecmode:v:113:y:2022:i:c:s0264999322001432.

Full description at Econpapers || Download paper

2021Group firms’ access to internal capital markets: The contingent roles of group resources and affiliates’ financial weakness. (2021). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: Economic Modelling. RePEc:eee:ecmode:v:96:y:2021:i:c:p:135-156.

Full description at Econpapers || Download paper

2021Pooled procurement of drugs in low and middle income countries. (2021). Straub, Stephane ; Lefouili, Yassine ; Dubois, Pierre. In: European Economic Review. RePEc:eee:eecrev:v:132:y:2021:i:c:s0014292121000088.

Full description at Econpapers || Download paper

2021Overcoming inefficiencies in the development of personalized medicine. (2021). Wuttke, David A ; Heese, Sebastian H ; Lutkemeyer, Daniel. In: European Journal of Operational Research. RePEc:eee:ejores:v:290:y:2021:i:1:p:278-296.

Full description at Econpapers || Download paper

2022Influenza vaccine supply chain coordination under uncertain supply and demand. (2022). Lev, Benjamin ; Zhao, Qiuhong ; Lin, QI. In: European Journal of Operational Research. RePEc:eee:ejores:v:297:y:2022:i:3:p:930-948.

Full description at Econpapers || Download paper

2022Bridging the low-carbon technology gap? Assessing energy initiatives for the Global South. (2022). Goldthau, Andreas ; Weko, Silvia. In: Energy Policy. RePEc:eee:enepol:v:169:y:2022:i:c:s0301421522004128.

Full description at Econpapers || Download paper

2022Pharmaceutical net price transparency across european markets: Insights from a multi-agent simulation model. (2022). van Dyck, Walter ; Swoboda, Torben ; Riccaboni, Massimo. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:6:p:534-540.

Full description at Econpapers || Download paper

2022The effect of patented drug price on the share of new medicines across OECD countries. (2022). Grootendorst, Paul ; Spicer, Oliver. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:8:p:795-801.

Full description at Econpapers || Download paper

2021Welfare effects of public procurement of medicines: Evidence from Ecuador. (2021). Mohapatra, Debi Prasad ; Callejas, Jeronimo. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:75:y:2021:i:c:s016771872030120x.

Full description at Econpapers || Download paper

2021Mergers and innovation: Evidence from the hard disk drive market. (2021). Ormosi, Peter ; Mariuzzo, Franco ; Davies, Stephen ; Bennato, Anna Rita. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:77:y:2021:i:c:s0167718721000485.

Full description at Econpapers || Download paper

2022Incentives for pharmaceutical innovation: What’s working, what’s lacking. (2022). Kyle, Margaret K. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000261.

Full description at Econpapers || Download paper

2022Which policies for vaccine innovation and delivery in Europe?. (2022). Dewatripont, Mathias. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000340.

Full description at Econpapers || Download paper

2021Capital, aggregate risk, insurance prices and regulation. (2021). Wang, Jinjing ; Subramanian, Ajay. In: Insurance: Mathematics and Economics. RePEc:eee:insuma:v:100:y:2021:i:c:p:156-192.

Full description at Econpapers || Download paper

2021Hospital multi-dimensional quality competition with medical malpractice. (2021). CHOPARD, Bertrand ; Bell-Aldeghi, Rosalind. In: International Review of Law and Economics. RePEc:eee:irlaec:v:68:y:2021:i:c:s0144818821000491.

Full description at Econpapers || Download paper

2021Economic capital and RAROC in a dynamic model. (2021). Zanjani, George ; Bauer, Daniel. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:125:y:2021:i:c:s0378426621000297.

Full description at Econpapers || Download paper

2022Value creation in an algorithmic world: Towards an ethics of dynamic pricing. (2022). di Domenico, Marialaura ; Nunan, Daniel. In: Journal of Business Research. RePEc:eee:jbrese:v:150:y:2022:i:c:p:451-460.

Full description at Econpapers || Download paper

2022Division of labor in R&D? Firm size and specialization in corporate research. (2022). Hottenrott, Hanna ; Mukherjee, Anwesha ; Becker, Annette. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:194:y:2022:i:c:p:1-23.

Full description at Econpapers || Download paper

2022Paying for pharmaceuticals: uniform pricing versus two-part tariffs. (2022). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Journal of Health Economics. RePEc:eee:jhecon:v:83:y:2022:i:c:s0167629622000339.

Full description at Econpapers || Download paper

2021Cross-border mergers and acquisitions for innovation. (2021). HSU, Po-Hsuan ; Humphery-Jenner, Mark ; Huang, Peng ; Powell, Ronan. In: Journal of International Money and Finance. RePEc:eee:jimfin:v:112:y:2021:i:c:s026156062030276x.

Full description at Econpapers || Download paper

2022Mine offtake contracting, strategic alliances and the equity market. (2022). Ferguson, Andrew ; Distadio, Luiz Fernando . In: Journal of Commodity Markets. RePEc:eee:jocoma:v:27:y:2022:i:c:s240585132100057x.

Full description at Econpapers || Download paper

2021Insurance and geopolitical risk: Fresh empirical evidence. (2021). Nakhli, Mohamed Sahbi ; Hemrit, Wael. In: The Quarterly Review of Economics and Finance. RePEc:eee:quaeco:v:82:y:2021:i:c:p:320-334.

Full description at Econpapers || Download paper

2021Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling. (2021). Chatterjee, Chirantan ; Yan, Xin ; Higgins, Matthew J. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:1:s0048733320302018.

Full description at Econpapers || Download paper

2021Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials. (2021). Häussler, Carolin ; Assmus, Anne ; Haeussler, Carolin . In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:2:s0048733320302298.

Full description at Econpapers || Download paper

2022Founder social capital and value appropriation in R&D alliance agreements. (2022). Tadikonda, Harsha ; Reuer, Jeffrey J ; Devarakonda, Ramakrishna. In: Research Policy. RePEc:eee:respol:v:51:y:2022:i:4:s0048733322000026.

Full description at Econpapers || Download paper

2021Legal Fees, Cost-Shifting Rules and Litigation: Experimental Evidence. (2021). Tisserand, Jean-Christian ; Peterle, Emmanuel ; Gabuthy, Yannick. In: Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics). RePEc:eee:soceco:v:93:y:2021:i:c:s2214804321000458.

Full description at Econpapers || Download paper

2022Curing is caring? Liability reforms, defensive medicine and malpractice litigation in a post-pandemic world. (2022). Sacco, Pier Luigi ; Russu, Paolo ; Maccioni, Alessandro Fiori ; Antoci, Angelo. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:80:y:2022:i:c:s0038012121001567.

Full description at Econpapers || Download paper

2021Product patents and access to innovative medicines. (2021). Watal, Jayashree ; Dai, Rong. In: Social Science & Medicine. RePEc:eee:socmed:v:291:y:2021:i:c:s027795362100811x.

Full description at Econpapers || Download paper

2022Does price-cap regulation work for increasing access to contraceptives? Aggregate- and pharmacy-level evidence from Colombia. (2022). Rodriguez Lesmes, Paul ; Mantilla, César ; Rodriguez-Lesmes, Paul ; Ortiz, Santiago ; Morales, Alvaro ; Andia, Tatiana. In: Social Science & Medicine. RePEc:eee:socmed:v:311:y:2022:i:c:s0277953622006189.

Full description at Econpapers || Download paper

2022How does CEO technical expertise influence licensing-out at technology ventures?. (2022). Ener, Hakan. In: Technovation. RePEc:eee:techno:v:114:y:2022:i:c:s0166497222000487.

Full description at Econpapers || Download paper

2022International collaboration and innovation: Evidence from a leading Chinese multinational enterprise. (2022). Hou, Jun ; Ghauri, Pervez ; Fu, Xiaoqing. In: Journal of World Business. RePEc:eee:worbus:v:57:y:2022:i:4:s1090951622000220.

Full description at Econpapers || Download paper

2021Does NICE influence the adoption and uptake of generics in the UK?. (2021). Oneill, Phill ; Mestre-Ferrandiz, Jorge ; Bianchi, Simona ; Serra-Sastre, Victoria. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:113639.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2021Effects of R&D Investments and Market Signals on International Acquisitions: Evidence from IPO Firms. (2021). Reuer, Jeffrey J ; Wu, Cheng-Wei. In: JRFM. RePEc:gam:jjrfmx:v:14:y:2021:i:5:p:191-:d:541083.

Full description at Econpapers || Download paper

2021The Impact of Mergers and Acquisitions and Sustainability on Company Performance in the Pharmaceutical Sector. (2021). Opreana, Alin ; Erban, Radu-Alexandru ; Mihaiu, Diana Marieta ; Barbu, Liliana ; Brtian, Vasile ; Ichindelean, Mihai. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:12:p:6525-:d:570910.

Full description at Econpapers || Download paper

2021Drug Discovery Firms and Business Alliances for Sustainable Innovation. (2021). Kodama, Kota ; Wang, Huayi ; Harada, Yoshimi ; Sengoku, Shintaro. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:7:p:3599-:d:523033.

Full description at Econpapers || Download paper

2022Pricing Problems in the Pharmaceutical Supply Chain with Mixed Channel: A Power Perspective. (2022). Zheng, YI ; Liu, LI ; Yang, Xiaojie ; Sun, Shanlin. In: Sustainability. RePEc:gam:jsusta:v:14:y:2022:i:12:p:7420-:d:841225.

Full description at Econpapers || Download paper

2022UNDERSTANDING CROSS-COUNTRY DIFFERENCES IN HEALTH STATUS AND EXPENDITURES. (2022). Sopraseuth, Thepthida ; Michaud, Pierre-Carl ; Langot, Franois ; Fonseca, Raquel. In: Working Papers. RePEc:hal:wpaper:hal-03679009.

Full description at Econpapers || Download paper

2022Impact of Mergers and Acquisitions on Innovation: Evidence from a Panel of Indian Pharmaceutical Firms. (2022). Jaiswal, Neha ; Basant, Rakesh. In: IIMA Working Papers. RePEc:iim:iimawp:14670.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2021The Right to Health and the Health Effects of Denials. (2021). Fernandez Sierra, Manuel ; Bhalotra, Sonia R. In: IZA Discussion Papers. RePEc:iza:izadps:dp14685.

Full description at Econpapers || Download paper

2022Teamwork in health care and medical malpractice liability: an experimental investigation. (2022). Martin-Lapoirie, Dylan. In: European Journal of Law and Economics. RePEc:kap:ejlwec:v:54:y:2022:i:2:d:10.1007_s10657-021-09708-3.

Full description at Econpapers || Download paper

2021Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy. (2021). naegelen, florence ; Marechal, Franois ; Alcenat, Stephane. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:21:y:2021:i:1:d:10.1007_s10754-020-09290-2.

Full description at Econpapers || Download paper

2021Earnings management surrounding forced CEO turnover: evidence from the U.S. property-casualty insurance industry. (2021). Lin, Tzuting ; Cummins, David J ; Cheng, Jiang. In: Review of Quantitative Finance and Accounting. RePEc:kap:rqfnac:v:56:y:2021:i:3:d:10.1007_s11156-020-00910-z.

Full description at Econpapers || Download paper

2021Cross-Examination. (2021). Fluet, Claude ; Lanzi, Thomas. In: Cahiers de recherche. RePEc:lvl:crrecr:2108.

Full description at Econpapers || Download paper

2021Payment Models for Multi-Indication Therapies. (2021). Neri, Margherita ; Cookson, G ; Cole, A. In: Consulting Reports. RePEc:ohe:conrep:002380.

Full description at Econpapers || Download paper

2021Under pressure: investment behaviour of insurers under different financial and regulatory conditions. (2021). Reddic, Willie Dion. In: The Geneva Papers on Risk and Insurance - Issues and Practice. RePEc:pal:gpprii:v:46:y:2021:i:1:d:10.1057_s41288-020-00174-7.

Full description at Econpapers || Download paper

2022Local religious beliefs and insurance companies’ risk-taking behaviour. (2022). Xu, Jianren ; Berry-Stolzle, Thomas R. In: The Geneva Papers on Risk and Insurance - Issues and Practice. RePEc:pal:gpprii:v:47:y:2022:i:2:d:10.1057_s41288-021-00211-z.

Full description at Econpapers || Download paper

2021Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?. (2021). Versaevel, Bruno ; Scannell, Jack ; de Villemeur, Etienne Billette. In: MPRA Paper. RePEc:pra:mprapa:108233.

Full description at Econpapers || Download paper

2021Optimal mixed payment system and medical liability. A laboratory study. (2021). Lisi, Domenico ; Guccio, Calogero ; Ferrara, Paolo Lorenzo ; Castro, Massimo Finocchiaro. In: MPRA Paper. RePEc:pra:mprapa:110276.

Full description at Econpapers || Download paper

2022Efficient Liability in Expert Markets. (2022). Zhang, Jin ; Li, Jianpei ; Chen, Yongmin. In: MPRA Paper. RePEc:pra:mprapa:112187.

Full description at Econpapers || Download paper

2022Market for Artificial Intelligence in Health Care and Compensation for Medical Errors. (2022). Musy, Olivier ; Chopard, Bertrand. In: MPRA Paper. RePEc:pra:mprapa:113328.

Full description at Econpapers || Download paper

2022City and Regional Demand for Vaccines Whose Supply Arises from Competition in a Bertrand Duopoly. (2022). Beladi, Hamid ; Batabyal, Amitrajeet. In: MPRA Paper. RePEc:pra:mprapa:113758.

Full description at Econpapers || Download paper

2022Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis. (2022). Lai, Ching-Chong ; Lu, You-Xun ; Hu, Mei-Ying. In: MPRA Paper. RePEc:pra:mprapa:113923.

Full description at Econpapers || Download paper

2021The Long Shadow of an Infection: COVID-19 and Performance at Work. (2021). Schmal, Wolfgang ; Reade, J ; Fischer, Kai. In: Economics Discussion Papers. RePEc:rdg:emxxdp:em-dp2021-17.

Full description at Econpapers || Download paper

2022Estimating Value-Based Price and Quantifying Uncertainty around It in Health Technology Assessment: Frequentist and Bayesian Approaches. (2022). Shiroiwa, Takeru ; Hagiwara, Yasuhiro. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:5:p:672-683.

Full description at Econpapers || Download paper

2021Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment. (2021). Shaikh, Mujaheed ; Kourouklis, Dimitrios ; Giudice, Pietro. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00601-9.

Full description at Econpapers || Download paper

2021Price Reduction of Anticancer Drugs from 2007 to 2019 in South Korea: The Impact of Pharmaceutical Cost-Containment Policies. (2021). Park, Chul ; Na, Young-Jin ; Kwon, Sun-Hong ; Shin, Ju-Young ; Kim, Hye-Lin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00604-6.

Full description at Econpapers || Download paper

2021Innovation spillover and merger decisions. (2021). Entezarkheir, Mahdiyeh ; Moshiri, Saeed. In: Empirical Economics. RePEc:spr:empeco:v:61:y:2021:i:5:d:10.1007_s00181-020-01973-6.

Full description at Econpapers || Download paper

2021Does NICE influence the adoption and uptake of generics in the UK?. (2021). Oneill, Phill ; Mestre-Ferrandiz, Jorge ; Bianchi, Simona ; Serra-Sastre, Victoria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:2:d:10.1007_s10198-020-01245-1.

Full description at Econpapers || Download paper

2021Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study. (2021). Korhonen, Marko ; Nerg, Iiro ; Ala-Mursula, Leena ; Rissanen, Ina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:4:d:10.1007_s10198-021-01271-7.

Full description at Econpapers || Download paper

2021Innovation crisis in the pharmaceutical industry? A survey. (2021). Backfisch, Martin ; Laermann-Nguyen, Ute. In: SN Business & Economics. RePEc:spr:snbeco:v:1:y:2021:i:12:d:10.1007_s43546-021-00163-5.

Full description at Econpapers || Download paper

2021Knowledge dynamics in employee entrepreneurship : Implications for parents and offspring. (2021). Chila, Vilma. In: Other publications TiSEM. RePEc:tiu:tiutis:a1f5d18c-783b-4af6-8414-61a224f6a525.

Full description at Econpapers || Download paper

2021Price cap regulation in the Colombian pharmaceutical market: An impact evaluation. (2021). Bardey, David ; Zuluaga, Daniela ; Harker, Arturo. In: TSE Working Papers. RePEc:tse:wpaper:125385.

Full description at Econpapers || Download paper

2022Bargaining and International Reference Pricing in the Pharmaceutical Industry. (2022). Vasserman, Shoshana ; Gandhi, Ashvin ; Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:126993.

Full description at Econpapers || Download paper

2021Cross-Examination.. (2021). Lanzi, Thomas ; Fluet, Claude. In: Working Papers of BETA. RePEc:ulp:sbbeta:2021-40.

Full description at Econpapers || Download paper

2022Fehlzeitenreport 2022. Krankheits- und unfallbedingte Fehlzeiten in Österreich. (2022). Bittschi, Benjamin ; Mayrhuber, Christine. In: WIFO Studies. RePEc:wfo:wstudy:69809.

Full description at Econpapers || Download paper

2022Do doctors prescribe antibiotics out of fear of malpractice?. (2022). Panthofer, Sebastian . In: Journal of Empirical Legal Studies. RePEc:wly:empleg:v:19:y:2022:i:2:p:340-381.

Full description at Econpapers || Download paper

2021A reply to “Who would benefit from average value?based pricing?”. (2021). Pertile, Paolo ; Levaggi, Rosella. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:9:p:2284-2286.

Full description at Econpapers || Download paper

2023Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany. (2023). Birg, Laura. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:2:p:302-323.

Full description at Econpapers || Download paper

2023More cost?sharing, less cost? Evidence on reference price drugs. (2023). Wenzel, Tobias ; Stuhmeier, Torben ; Herr, Annika. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:2:p:413-435.

Full description at Econpapers || Download paper

2021INNOVATION AND DIFFUSION OF MEDICAL TREATMENT. (2021). Papageorge, Nicholas ; Hamilton, Barton H ; Miller, Robert A ; Hincapie, Andres. In: International Economic Review. RePEc:wly:iecrev:v:62:y:2021:i:3:p:953-1009.

Full description at Econpapers || Download paper

2022EFFICIENT LIABILITY IN EXPERT MARKETS. (2022). Zhang, Jin ; Li, Jianpei ; Chen, Yongmin. In: International Economic Review. RePEc:wly:iecrev:v:63:y:2022:i:4:p:1717-1744.

Full description at Econpapers || Download paper

2021The Right to Health and the Health Effects of Denials. (2021). Fernandez, Manuel ; Bhalotra, Sonia. In: The Warwick Economics Research Paper Series (TWERPS). RePEc:wrk:warwec:1376.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany. (2022). Righetti, G ; Pertile, P ; Gamba, S. In: Health, Econometrics and Data Group (HEDG) Working Papers. RePEc:yor:hectdg:22/20.

Full description at Econpapers || Download paper

2021The long shadow of an infection: COVID-19 and performance at work. (2021). Schmal, Wolfgang ; Reade, J ; Fischer, Kai. In: DICE Discussion Papers. RePEc:zbw:dicedp:368.

Full description at Econpapers || Download paper

Patricia M. Danzon has edited the books:


YearTitleTypeCited

Works by Patricia M. Danzon:


YearTitleTypeCited
1988The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review.
[Full Text][Citation analysis]
article2
1990The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review.
[Full Text][Citation analysis]
article7
.() In: .
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 7
paper
1991Liability for Medical Malpractice In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article75
2000Liability for medical malpractice.(2000) In: Handbook of Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 75
chapter
1994Health Care Reform In: Australian Economic Review.
[Full Text][Citation analysis]
article6
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article61
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 61
chapter
2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 61
paper
1994The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics.
[Full Text][Citation analysis]
article3
2008Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance.
[Full Text][Citation analysis]
article10
1997Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation.
[Full Text][Citation analysis]
article93
2000Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics.
[Full Text][Citation analysis]
article92
1982Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics.
[Full Text][Citation analysis]
article16
2002Welfare effects of supplementary insurance: a comment In: Journal of Health Economics.
[Full Text][Citation analysis]
article10
2005Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics.
[Full Text][Citation analysis]
article79
2003Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 79
paper
1985Liability and liability insurance for medical malpractice In: Journal of Health Economics.
[Full Text][Citation analysis]
article19
1984Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics.
[Full Text][Citation analysis]
article4
2012Regulation of the Biopharmaceutical Industry In: Chapters.
[Full Text][Citation analysis]
chapter0
1990THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME. In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
paper4
1990Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
paper2
2002Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs.
[Full Text][Citation analysis]
paper0
2007At what price? In: Nature.
[Full Text][Citation analysis]
article3
2014Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters.
[Full Text][Citation analysis]
chapter3
1999The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters.
[Full Text][Citation analysis]
chapter2
2004Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers.
[Full Text][Citation analysis]
paper63
2007Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 63
article
2008Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper23
2011Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers.
[Full Text][Citation analysis]
paper15
2015Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15
article
2011Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers.
[Full Text][Citation analysis]
paper5
2011Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 5
article
2011Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper19
2012Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers.
[Full Text][Citation analysis]
paper17
2015Value?Based Differential Pricing: Efficient Prices for Drugs in a Global Context.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 17
article
2002Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers.
[Full Text][Citation analysis]
paper66
2003The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers.
[Full Text][Citation analysis]
paper75
2005The impact of price regulation on the launch delay of new drugs—evidence from twenty?five major markets in the 1990s.(2005) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 75
article
1997Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monograph.
[Full Text][Citation analysis]
book5
2000Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monograph.
[Full Text][Citation analysis]
book4
2002The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monograph.
[Full Text][Citation analysis]
book7
2011Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Paper.
[Full Text][Citation analysis]
paper2
1994Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy.
[Citation analysis]
article1
1990Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article4
1983Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics.
[Full Text][Citation analysis]
article49
2018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics.
[Full Text][Citation analysis]
article11
2015Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article0
1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article34
1993The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics.
[Full Text][Citation analysis]
article13
2002Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics.
[Full Text][Citation analysis]
article19
1984The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article36
1993Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article0
2000Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics.
[Full Text][Citation analysis]
article103
2001Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article11
1997Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article6
2001Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article0
1994Price Cutting in Liability Insurance Markets. In: The Journal of Business.
[Full Text][Citation analysis]
article27
2000Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business.
[Full Text][Citation analysis]
article6
2002A general model of the impact of absenteeism on employers and employees In: Health Economics.
[Full Text][Citation analysis]
article34
1999Medical negligence and the NHS: an economic analysis In: Health Economics.
[Full Text][Citation analysis]
article8
1995A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1982Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article1
2007Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics.
[Full Text][Citation analysis]
article4
In: .
[Full Text][Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2023. Contact: CitEc Team